With the ever-increasing number of DM patients and its negative effect on economy, health system and society, there has been a need for rapid progress in the care and management of patients with insulin treatment which, by improving glycemic control, slows down the progress of microvascular and macrovascular complications [5,6]. This evidence concerns the gene INS and diabetes mellitus.